Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
BeOne
Pharma
BeOne’s Brukinsa hits goal in lymphoma confirmatory trial
Overall survival data will likely be key in BeOne’s approval bid, given Imbruvica’s earlier U.S. withdrawal in MCL.
Angus Liu
Jun 30, 2026 6:00am
BeOne boosts support for Blood Cancer United with $5M commitment
Jun 26, 2026 3:57am
Akeso's 34% overall survival win comes with caveats
May 31, 2026 8:00am
Previewing Akeso's high-stakes ASCO plenary for PD-1/VEGF
May 27, 2026 11:25am
BeOne kicks off ‘One Save’ campaign with Tim Howard
May 20, 2026 6:00am
BeOne's Venclexta challenger Beqalzi nets FDA approval
May 13, 2026 4:45pm
